LAUER REGAN J has filed 26 insider transactions across 1 company since June 2023.
Most recent transaction: a option exercise of 4065 shares of ImmunityBio, Inc. ($IBRX) on February 22, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 4065 | $0.00 | 4,065.0000 | 984,965,179 | 50.00% | 0.00% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | F | Common Stock | 1673 | $8.70 | 115,875.0000 | 984,965,179 | 1.42% | 0.00% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 4065 | $0.00 | 117,548.0000 | 984,965,179 | 3.58% | 0.00% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 5482 | $0.00 | 10,965.0000 | 984,965,179 | 33.33% | 0.00% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | F | Common Stock | 2257 | $6.93 | 113,483.0000 | 984,965,179 | 1.95% | 0.00% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 5482 | $0.00 | 115,740.0000 | 984,965,179 | 4.97% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 4065 | $0.00 | 111,927.0000 | 852,904,340 | 3.77% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | F | Common Stock | 1669 | $3.42 | 110,258.0000 | 852,904,340 | 1.49% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 4065 | $0.00 | 8,130.0000 | 852,904,340 | 33.33% | 0.00% |
| Feb. 10, 2025 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | A | Restricted Stock Units | 16447 | $0.00 | 16,447.0000 | 852,904,340 | 9999.99% | 0.00% |
| Feb. 10, 2025 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | A | Stock Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 852,904,340 | 9999.99% | 0.01% |
| Dec. 15, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 21031 | $0.00 | 0.0000 | 696,831,296 | 100.00% | 0.00% |
| Dec. 15, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 21031 | $0.00 | 115,365.0000 | 696,831,296 | 22.29% | 0.00% |
| Dec. 15, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | F | Common Stock | 7503 | $2.87 | 107,862.0000 | 696,831,296 | 6.50% | 0.00% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | A | Stock Option (right to buy) | 42439 | $0.00 | 42,439.0000 | 670,867,344 | 9999.99% | 0.01% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | A | Restricted Stock Units | 12195 | $0.00 | 12,195.0000 | 670,867,344 | 9999.99% | 0.00% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | F | Common Stock | 13470 | $3.36 | 94,334.0000 | 670,867,344 | 12.49% | 0.00% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 32872 | $0.00 | 0.0000 | 670,867,344 | 100.00% | 0.00% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 32872 | $0.00 | 107,804.0000 | 670,867,344 | 43.87% | 0.00% |
| Dec. 15, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 21030 | $0.00 | 21,031.0000 | 421,569,115 | 50.00% | 0.00% |
| Dec. 15, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 21030 | $0.00 | 74,932.0000 | 421,569,115 | 39.02% | 0.00% |
| Sept. 1, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 32872 | $0.00 | 53,902.0000 | 421,569,115 | 156.31% | 0.01% |
| Sept. 1, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 32872 | $0.00 | 32,872.0000 | 421,569,115 | 50.00% | 0.01% |
| Aug. 25, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | A | Restricted Stock Units | 65744 | $0.00 | 65,744.0000 | 421,569,115 | 9999.99% | 0.02% |
| June 15, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Common Stock | 21030 | $0.00 | 21,030.0000 | 421,569,115 | 9999.99% | 0.00% |
| June 15, 2023 | ImmunityBio, Inc. | $IBRX | LAUER REGAN J | Chief Accounting Officer | M | Restricted Stock Units | 21030 | $0.00 | 42,061.0000 | 421,569,115 | 33.33% | 0.00% |